Vijayavitthal Thippannachar Mathad
Research Subjects
Research Interests
Vijayavitthal Thippannachar Mathad has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Pavankumar V. Solanki
Department of Process Research and Development, Megafine Pharma (P) Ltd., Lakhmapur, Dindori, Nashik 422202, Maharashtra, India
6 shared publicationsNavnath C. Niphade
Megafine Pharma (P) Ltd
4 shared publicationsSekhar Babu Uppelli
Department of Process Research and Development, Megafine Pharma (P) Ltd., Lakhmapur, Dindori, Nashik 422202, Maharashtra, India
4 shared publicationsAnil C. Mali
Department of Process Research and Development, Megafine Pharma (P) Ltd., Dindori, Nashik-422 202, Maharashtra, India
3 shared publications- Bal Raju Kammari
Polymorph Screening and Development Laboratory, R&D center, MSN Laboratories (P) Ltd., Plot No.12, IDA Pashamylaram, Patancheru, Hyderabad 502307, Telangana, India
3 shared publications Eswaraiah Sajja
Research and Development, MSN Laboratories (P) Ltd., Plot No.12, IDA Pashamylaram, Patancheru, Hyderabad 502307, Telangana, India
3 shared publications
Latest Publications
- 16 October 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (11) , 8065-8075
Novel Pharmaceutical Cocrystal of Voxelotor, a Hemoglobin Oxygen Affinity Modulator: Synthesis, Crystal Structure, and Physicochemical Properties
- 16 October 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (11) , 8065-8075
Novel Pharmaceutical Cocrystal of Voxelotor, a Hemoglobin Oxygen Affinity Modulator: Synthesis, Crystal Structure, and Physicochemical Properties
- 16 November 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (12) , 3265-3275
Efficient Process for Obeticholic Acid: Synthesis, Structural Assignment, and Control Strategy for Diastereoisomeric Impurities
- 16 November 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (12) , 3265-3275
Efficient Process for Obeticholic Acid: Synthesis, Structural Assignment, and Control Strategy for Diastereoisomeric Impurities
- Open Access
- 15 February 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (8) , 7032-7044
Stable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties
Exploration of alternate solid forms for dasatinib, a potent oncogene tyrosine kinase inhibitor classified under Biopharmaceutics Classification System (BCS) class II drugs with low water solubility and high permeability, has been performed using COSMO-RS excess enthalpy (Hex) to increase dissolution. The theoretical prediction resulted in the potential for the formation of C6–C8 fatty acid solvates with dasatinib. A crystallization process has been identified for the preparation of the predicted solvates and successfully scaled up till the 100 g level. The fatty acid solvates are completely characterized using powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), Fourier transform infrared (FT-IR) spectroscopy, and proton nuclear magnetic resonance (1H NMR) spectroscopy. Unique powder X-ray diffraction patterns and powder indexing of C6–C8 fatty acid solvates indicate the purity of the solid phase. The red shift in the acid carbonyl stretching frequency of C6–C8 fatty acids in FT-IR spectra and the intactness of the fatty acid proton in 1H-NMR spectra provide evidence for solvate formation. The stoichiometry of active pharmaceutical ingredients (APIs) with solvent in solvates is measured using TGA and 1H-NMR spectroscopy. Dasatinib C6–C8 fatty acid solvates were found to retain their solid form under various stress and pharmaceutical processing conditions. In addition, they exhibited improved powder dissolution over dasatinib Form H1-7 by 2.2-fold. They also showed stability at 40 °C and 75% RH for 3 months. C8 fatty acid is a USFDA GRAS listed solvent, and hence may be a viable option for drug product development.
- 15 February 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (8) , 7032-7044
Open AccessStable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties
Exploration of alternate solid forms for dasatinib, a potent oncogene tyrosine kinase inhibitor classified under Biopharmaceutics Classification System (BCS) class II drugs with low water solubility and high permeability, has been performed using COSMO-RS excess enthalpy (Hex) to increase dissolution. The theoretical prediction resulted in the potential for the formation of C6–C8 fatty acid solvates with dasatinib. A crystallization process has been identified for the preparation of the predicted solvates and successfully scaled up till the 100 g level. The fatty acid solvates are completely characterized using powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), Fourier transform infrared (FT-IR) spectroscopy, and proton nuclear magnetic resonance (1H NMR) spectroscopy. Unique powder X-ray diffraction patterns and powder indexing of C6–C8 fatty acid solvates indicate the purity of the solid phase. The red shift in the acid carbonyl stretching frequency of C6–C8 fatty acids in FT-IR spectra and the intactness of the fatty acid proton in 1H-NMR spectra provide evidence for solvate formation. The stoichiometry of active pharmaceutical ingredients (APIs) with solvent in solvates is measured using TGA and 1H-NMR spectroscopy. Dasatinib C6–C8 fatty acid solvates were found to retain their solid form under various stress and pharmaceutical processing conditions. In addition, they exhibited improved powder dissolution over dasatinib Form H1-7 by 2.2-fold. They also showed stability at 40 °C and 75% RH for 3 months. C8 fatty acid is a USFDA GRAS listed solvent, and hence may be a viable option for drug product development.
- 12 January 2022
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 22 (2) , 1130-1142
Novel Pharmaceutical Cocrystal of Apalutamide, a Nonsteroidal Antiandrogen Drug: Synthesis, Crystal Structure, Dissolution, Stress, and Excipient Compatibility
- 12 January 2022
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 22 (2) , 1130-1142
Novel Pharmaceutical Cocrystal of Apalutamide, a Nonsteroidal Antiandrogen Drug: Synthesis, Crystal Structure, Dissolution, Stress, and Excipient Compatibility
- Open Access
- 29 May 2018
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 3 (5) , 5744-5753
Facile Synthesis of Dabigatran Etexilate Mesylate, an Anticoagulant Drug, Using a Novel Synthon, N-Hexyl-4-nitrophenyl Carbonate
Facile synthesis for Dabigatran etexilate mesylate (1), an anticoagulant drug, is reported using a novel synthon, n-hexyl-4-nitrophenyl carbonate (32), which substantially eliminates the formation of potential impurities 20–27, which were generated due to the use of n-hexyl chloroformate in previously reported methods. Pinner reaction to prepare a key and critical intermediate, amidine 8, was optimized using design of experiment software to establish critical process parameters to achieve 8 in 97% yield. Nucleophilic substitution of 8 with novel synthon n-hexyl-4-nitrophenyl carbonate (32) furnished the dabigatran base 9, which was then converted to its mesylate salt using methane sulfonic acid to provide 1 with an overall yield of 66% over three steps.
- 29 May 2018
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 3 (5) , 5744-5753
Open AccessFacile Synthesis of Dabigatran Etexilate Mesylate, an Anticoagulant Drug, Using a Novel Synthon, N-Hexyl-4-nitrophenyl Carbonate
Facile synthesis for Dabigatran etexilate mesylate (1), an anticoagulant drug, is reported using a novel synthon, n-hexyl-4-nitrophenyl carbonate (32), which substantially eliminates the formation of potential impurities 20–27, which were generated due to the use of n-hexyl chloroformate in previously reported methods. Pinner reaction to prepare a key and critical intermediate, amidine 8, was optimized using design of experiment software to establish critical process parameters to achieve 8 in 97% yield. Nucleophilic substitution of 8 with novel synthon n-hexyl-4-nitrophenyl carbonate (32) furnished the dabigatran base 9, which was then converted to its mesylate salt using methane sulfonic acid to provide 1 with an overall yield of 66% over three steps.
- Open Access
- 20 March 2018
- Published by Slovenian Chemical Society in Acta Chimica Slovenica
- Vol. 65 (1) , 239-245
Investigation of Mechanistic Pathway for Trimethyl Borate Mediated Amidation of (R)-Mandelic Acid for the Synthesis of Mirabegron, an Antimuscarinic Agent
The present work describes investigation of mechanistic pathway for trimethyl borate mediated amidation of (R)-mandelic acid (3) with 4-nitophenylethylamine (2) to provide (R)-2-hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide (4) during mirabegron synthesis.Plausible reaction mechanism is proposedby isolating and elucidating the active α-hydroxy ester intermediate 16 from the reaction mass. Trimethylborate mediated approach proved to be selective in providing 4 without disturbing α-hydroxyl group and stereochemistry of chiral center, and is also a greener, economic and production friendly over the reported methods. The developed approach is rapid and efficient for the preparation of4with an overall yield of 85-87% and around 99.0% purity by HPLC at scale.
- 20 March 2018
- Published by Slovenian Chemical Society in Acta Chimica Slovenica
- Vol. 65 (1) , 239-245
Open AccessInvestigation of Mechanistic Pathway for Trimethyl Borate Mediated Amidation of (R)-Mandelic Acid for the Synthesis of Mirabegron, an Antimuscarinic Agent
The present work describes investigation of mechanistic pathway for trimethyl borate mediated amidation of (R)-mandelic acid (3) with 4-nitophenylethylamine (2) to provide (R)-2-hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide (4) during mirabegron synthesis.Plausible reaction mechanism is proposedby isolating and elucidating the active α-hydroxy ester intermediate 16 from the reaction mass. Trimethylborate mediated approach proved to be selective in providing 4 without disturbing α-hydroxyl group and stereochemistry of chiral center, and is also a greener, economic and production friendly over the reported methods. The developed approach is rapid and efficient for the preparation of4with an overall yield of 85-87% and around 99.0% purity by HPLC at scale.
- 16 January 2018
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 149 (3) , 653-661
Improved and single-pot process for the synthesis of macitentan, an endothelin receptor antagonist, via lithium amide-mediated nucleophilic substitution
- 16 January 2018
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 149 (3) , 653-661
Improved and single-pot process for the synthesis of macitentan, an endothelin receptor antagonist, via lithium amide-mediated nucleophilic substitution
- 15 January 2018
- Published by Bentham Science Publishers Ltd. in Current Green Chemistry
- Vol. 4 (3) , 1-10
Practical and Green Process for the Synthesis of Ivabradine Hydrochloride Through an Efficient Control of Process Impurities
Abstract: Background: Synthetic processes reported for ivabradine hydrochloride (1), a heart rate lowering drug (an antianginal agent), are inefficient and uneconomical at an industrial scale due to their inability to control the formation of process related impurities. Generation of huge amount of solvent and solid waste due to repeated purifications and/or chromatographic purifications to eliminate impurities makes them industrially unsuitable hence requires the development of practical and greener process for 1. Method: Based on the spectral analysis and synthetic route followed for 1, the structures for the impurities were identified and confirmed by their synthesis. Evaluated the genesis of these impurities based on the mechanistic understanding of the reaction pathways and established suitable strategies to eliminate/ minimize by optimizing the process parameters. The greenness and productivity of newly developed process were determined using process evaluation benchmarks such as process mass intensity (PMI), e-factor, atom economy, and volume time output (VTO). Results: Established process delivered greener, productive and efficient method for 1 with an overall yield of around 62.0% and HPLC purity of >99.9%. Conclusion: An efficient, economic and industrially feasible process for the synthesis of 1 is established which not only controls the formation of impurities but also minimizes the aqueous, organic and solid waste substantially to achieve the greener and productive process.
- 15 January 2018
- Published by Bentham Science Publishers Ltd. in Current Green Chemistry
- Vol. 4 (3) , 1-10
Practical and Green Process for the Synthesis of Ivabradine Hydrochloride Through an Efficient Control of Process Impurities
Abstract: Background: Synthetic processes reported for ivabradine hydrochloride (1), a heart rate lowering drug (an antianginal agent), are inefficient and uneconomical at an industrial scale due to their inability to control the formation of process related impurities. Generation of huge amount of solvent and solid waste due to repeated purifications and/or chromatographic purifications to eliminate impurities makes them industrially unsuitable hence requires the development of practical and greener process for 1. Method: Based on the spectral analysis and synthetic route followed for 1, the structures for the impurities were identified and confirmed by their synthesis. Evaluated the genesis of these impurities based on the mechanistic understanding of the reaction pathways and established suitable strategies to eliminate/ minimize by optimizing the process parameters. The greenness and productivity of newly developed process were determined using process evaluation benchmarks such as process mass intensity (PMI), e-factor, atom economy, and volume time output (VTO). Results: Established process delivered greener, productive and efficient method for 1 with an overall yield of around 62.0% and HPLC purity of >99.9%. Conclusion: An efficient, economic and industrially feasible process for the synthesis of 1 is established which not only controls the formation of impurities but also minimizes the aqueous, organic and solid waste substantially to achieve the greener and productive process.
- Open Access
- 1 January 2018
- Published by Georg Thieme Verlag KG in SynOpen
- Vol. 2 (1) , 72-77
Synthesis of Cinacalcet Hydrochloride: A Case Study on the Impact of Agitation Speed on the Reaction Kinetics of Schiff's Base during Scale-up
During the process development of Cinacalcet hydrochloride, a calcimimetic agent, we encountered an unexpected substantial increase in the content of impurities in the product while scaling up the process in the pilot plant. Detailed investigation led to the conclusion that the agitation speed of the reaction mass impacted the reaction kinetics of Schiff's base, leading to the formation of the impurities and lowering the product yield to ca. 40%. The present work reports details of an investigation carried out to control the formation of impurities to achieve an efficient and one-pot process for Cinacalcet hydrochloride with an overall yield of ca. 70%.
- 1 January 2018
- Published by Georg Thieme Verlag KG in SynOpen
- Vol. 2 (1) , 72-77
Open AccessSynthesis of Cinacalcet Hydrochloride: A Case Study on the Impact of Agitation Speed on the Reaction Kinetics of Schiff's Base during Scale-up
During the process development of Cinacalcet hydrochloride, a calcimimetic agent, we encountered an unexpected substantial increase in the content of impurities in the product while scaling up the process in the pilot plant. Detailed investigation led to the conclusion that the agitation speed of the reaction mass impacted the reaction kinetics of Schiff's base, leading to the formation of the impurities and lowering the product yield to ca. 40%. The present work reports details of an investigation carried out to control the formation of impurities to achieve an efficient and one-pot process for Cinacalcet hydrochloride with an overall yield of ca. 70%.